Abstract
We report a case of a 65-year-old man with microscopic polyangiitis who developed prostate cancer and gastric adenocarcinoma after prolonged oral use of cyclophosphamide. Acute hepatitis with jaundice and marked increase in aminotranferases occurred after 6 months of flutamide treatment for metastatic prostate carcinoma. It is suggested that patients with vasculitis or other autoimmune disorders should avoid prolonged use of cyclophosphamide and other cytotoxic drugs in order to minimize long-term adverse effects, of which the risk of cancer is by far the most important. In patients on flutamide treatment, careful monitoring of flutamide administration with repeated liver function tests should be undertaken, and the drug must be immediately discontinued in patients with abnormal results to avoid progression of liver injury.
Similar content being viewed by others
References
F Lhote L Guillevin (1995) ArticleTitlePolyarteritis nodosa, microscopic polyangiitis, and Churg–Strauss syndrome clinical aspects and treatment Rheum Dis Clin North Am 21 9911–9947
L Guillevin B Durand-Gasselin R Cevallos et al. (1999) ArticleTitleMicroscopic polyangiitis. Clinical and laboratory findings in 85 patients Arthritis Rheum 42 421–430 Occurrence Handle10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6 Occurrence Handle1:STN:280:DyaK1M7os1Khtg%3D%3D Occurrence Handle10088763
D Lauque J Cadranel R Lazor et al. (2000) ArticleTitleMicroscopic polyangiitis with alveolar hemorrhageA study of 29 cases and review of the literature Medicine (Baltimore) 79 222–233 Occurrence Handle10.1097/00005792-200007000-00003 Occurrence Handle1:STN:280:DC%2BD3cvhsVGgtQ%3D%3D
COS Savage CG Winearls DJ Evans AJ Rees CM Lockwood (1985) ArticleTitleMicroscopic polyarteritis: presentation, pathology and prognosis Q J Med 56 467–483 Occurrence Handle1:STN:280:BimD3MjltFQ%3D Occurrence Handle4048389
D Adu A Pall RA Luqmani et al. (1997) ArticleTitleControlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis Q J Med 90 401–409 Occurrence Handle1:STN:280:ByiA2cbnsFM%3D
L Guillevin P Cohen A Mahr et al. (2003) ArticleTitleTreatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients Arthritis Care Res 49 93–100 Occurrence Handle10.1002/art.10922 Occurrence Handle1:CAS:528:DC%2BD3sXhslKmtrw%3D
D Jayne (2001) ArticleTitleUpdate on the European Vasculitis Study Group trials Curr Opin Rheumatol 13 48–55 Occurrence Handle1:STN:280:DC%2BD3M7isFSksw%3D%3D Occurrence Handle11148715
CA Langford (2001) ArticleTitleManagement of systemic vasculitis Best Pract Res Clin Rheumatol 15 281–297 Occurrence Handle10.1053/berh.2001.0144 Occurrence Handle1:CAS:528:DC%2BD38Xhs1Kktw%3D%3D Occurrence Handle11469822
GS Hoffman GS Kerr RY Leavitt et al. (1992) ArticleTitleWegener's grnulomatosis: an analysis of 158 patients Ann Intern Med 116 488–498 Occurrence Handle1:STN:280:By2C2M3lvFU%3D Occurrence Handle1739240
Hoffman GS. Vasculitides B. Wegener's Granulomatosis, Churg–Strauss Vasculitis. In: Klippel JH, Crofford LJ, Stone JH, Weyand CM, eds. Primer on the Rheumatic Diseases. 12 edn. Atlanta: Arthritis Foundation, 2001: 392–396.
CD Radis LE Kahl GL Baker et al. (1995) ArticleTitleEffects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year follow up study Arthritis Rheum 38 1120–1127 Occurrence Handle1:CAS:528:DyaK2MXns1WisLY%3D Occurrence Handle7639809
A Knight J Askling A Ekbom (2002) ArticleTitleCancer incidence in a population-based cohort of patients with Wegener's granulomatosis Int J Cancer 100 82–85 Occurrence Handle10.1002/ijc.10444 Occurrence Handle1:CAS:528:DC%2BD38XksVGntbs%3D Occurrence Handle12115591
KW Westman PG Bygren H Olsson J Ranstam J Wieslander (1998) ArticleTitleRelapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement J Am Soc Nephrol 9 842–852 Occurrence Handle1:STN:280:DyaK1c3lsFGhsw%3D%3D Occurrence Handle9596082
PC Sogani MR Vagaiwaala WF Whitmore SuffixJr (1984) ArticleTitleExperience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy Cancer 54 744–750 Occurrence Handle1:STN:280:BiuB2MfptVw%3D Occurrence Handle6378356
R Lundgren (1987) ArticleTitleFlutamide as primary treatment for metastatic prostatic cancer Br J Urol 59 156–158 Occurrence Handle1:STN:280:BiiC2Mflt1M%3D Occurrence Handle3828712
JL Gomez A Dupont L Cusan et al. (1992) ArticleTitleIncidence of liver toxicity associated with the use of flutamide in prostate cancer patients Am J Med 93 465–470
S Moller P Iversen MB Fransman (1990) ArticleTitleFlutamide-induced liver failure J Hepatol 10 346–349 Occurrence Handle10.1016/0168-8278(90)90144-G Occurrence Handle1:STN:280:By%2BA3cfisVA%3D Occurrence Handle2365984
DK Wysowski (1993) ArticleTitleFatal and non fatal hepatotoxicity associated with flutamide Ann Intern Med 118 860–864 Occurrence Handle1:STN:280:ByyB2czmtFU%3D Occurrence Handle7683180
SP Dourakis AA Alexopoulou SJ Hadziyannis (1994) ArticleTitleFulminant hepatitis after flutamide treatment J Hepatol 20 350–353 Occurrence Handle10.1016/S0168-8278(94)80006-5 Occurrence Handle1:STN:280:ByuB1cvlslw%3D Occurrence Handle8014445
DK Wysowski JL Fourcroy (1996) ArticleTitleFlutamide hepatotoxicity J Urol 155 209–212 Occurrence Handle1:CAS:528:DyaK28XktlyntLg%3D Occurrence Handle7490837
RL Crownover J Holland A Chen et al. (1996) ArticleTitleFlutamide-induced liver toxicity including fatal hepatic necrosis Int J Rad Oncol Biol Phys 34 911–915 Occurrence Handle10.1016/0360-3016(95)02107-8 Occurrence Handle1:CAS:528:DyaK28XisVCit74%3D
C Cicognani M Malavolti AM Morselli-Labate C Sama L Barbara (1996) ArticleTitleFlutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis Dig Dis Sci 14 2219–2221
M Cetin D Demirci A Unal et al. (1999) ArticleTitleFrequency of flutamide induced hepatotoxicity in patients with prostate carcinoma Hum Exp Toxicol 18 137–140 Occurrence Handle1:CAS:528:DyaK1MXitFCitbo%3D Occurrence Handle10215102
G Lazaros P Angelopoulou S Chryssou A Bourlis G Anagnostopoulos N Tassopoulos (2001) ArticleTitleFlutamide-induced hepatotoxicity Ann Gastroenterol 14 125–127
S Stefanidis D Dionysopoulos M Kotti E Gianoulis A Tourkantonis (2001) ArticleTitleFatal outcome of acute liver failure due to flutamide treatment Ann Gastroenterol 14 338–339
M Garcia Cortes RJ Andrade MI Lucena et al. (2001) ArticleTitleFlutamide-induced hepatotoxicity: report of a case series Rev Esp Enferm Dig 93 425–432
ED Crawford MA Eisenenberger DG McLeod et al. (1989) ArticleTitleA controlled trial of leuprolide with and without flutamide in prostatic carcinoma N Engl J Med 321 419–424 Occurrence Handle1:STN:280:BiaA2cvhtlE%3D Occurrence Handle2503724
JL Gomez A Dupont L Cusan M Tremblay F Labrie (1992) ArticleTitleSimultaneous liver, lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case report Am J Med 92 563–566 Occurrence Handle1:STN:280:By2B2MvovFY%3D Occurrence Handle1580304
L Dawson E Chow G Morton (1997) ArticleTitleFulminant hepatic failure associated with bicalutamide Urology 49 283–284 Occurrence Handle10.1016/S0090-4295(96)00355-X Occurrence Handle1:STN:280:ByiC1cbgt1M%3D Occurrence Handle9037299
S Sherlock (1986) ArticleTitleThe spectrum of hepatotoxicity due to drugs Lancet ii 440–444
RN Brodgen SP Clissold (1989) ArticleTitleFlutamide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer Drugs 38 185–203
D Fau D Eugene A Berson et al. (1994) ArticleTitleToxicity of the antiandrogen flutamide in isolated rat hepatocytes J Pharmacol Exp Ther 269 954–962 Occurrence Handle1:CAS:528:DyaK2cXksV2kt74%3D Occurrence Handle8014883
L Pontiroli M Sartori S Pittau S Morelli R Boldorini E Albano (1998) ArticleTitleFlutamide-induced acute hepatitis investigation of the role of immunoallergic mechanisms Ital J Gastroenterol Hepatol 30 310–314 Occurrence Handle1:STN:280:DyaK1cvjtFOltQ%3D%3D Occurrence Handle9759603
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Papaioannides, D., Korantzopoulos, P., Bouropoulos, C. et al. Microscopic Polyangiitis Complicated by the Development of Prostate Cancer and Flutamide-induced Hepatitis. Int Urol Nephrol 37, 515–520 (2005). https://doi.org/10.1007/s11255-005-2093-0
Issue Date:
DOI: https://doi.org/10.1007/s11255-005-2093-0